These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3244662)

  • 1. Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue.
    Chan TW; Becker A
    Pharm Res; 1988 Aug; 5(8):523-7. PubMed ID: 3244662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.
    Powell MF; Foster LC; Becker AR; Lee W
    Pharm Res; 1988 Aug; 5(8):528-32. PubMed ID: 3244663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physico-chemical properties of muroctasin.
    Moroi R; Yamazaki K; Hirota T; Watanabe S; Kataoka K; Ichinose M
    Arzneimittelforschung; 1988 Jul; 38(7A):953-9. PubMed ID: 3190802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle.
    Lidgate DM; Fu RC; Byars NE; Foster LC; Fleitman JS
    Pharm Res; 1989 Sep; 6(9):748-52. PubMed ID: 2813271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical modification of the C-6 substituent in the carbohydrate moiety of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP), and the immunoadjuvant activity.
    Okumura H; Tokushima Y; Saiki I; Azuma I; Kiso M; Hasegawa A
    Carbohydr Res; 1983 Oct; 122(1):87-98. PubMed ID: 6652634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of the β/α anomer composition within amorphous lactose prepared by spray and freeze drying using a simple (1)H-NMR method.
    Jawad R; Elleman C; Vermeer L; Drake AF; Woodhead B; Martin GP; Royall PG
    Pharm Res; 2012 Feb; 29(2):511-24. PubMed ID: 21901569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
    Durette PL; Dorn CP; Friedman A; Schlabach A
    J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
    Chang YH; Pearson CM; Chedid L
    J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the stability of muroctasin and degradation products built under extreme conditions.
    Moroi R; Yamazaki K; Hirota T; Watanabe S; Oki M; Toriyama M; Ichinohe A; Kataoka K
    Arzneimittelforschung; 1988 Jul; 38(7A):959-68. PubMed ID: 3190803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GMDP: unusual physico-chemical and biological properties of the anomeriс forms.
    Meshcheryakova EA; Mineev KS; Volynski PE; Andronova TM; Ivanov VT
    J Pept Sci; 2015 Sep; 21(9):717-22. PubMed ID: 26153038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunochemistry of tubercle bacilli, with special reference to adjuvant activity (author's transl)].
    Azuma I
    Kekkaku; 1981 Dec; 56(12):595-607. PubMed ID: 7035731
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].
    Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV
    Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
    Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
    Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological activities of multiprenylacetyl derivatives of muramyldipeptides.
    Azuma I; Saiki I; Iida J; Fukuda T; Kobayashi S
    Vaccine; 1988 Aug; 6(4):339-42. PubMed ID: 2847438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.
    Kim AI; Akers MJ; Nail SL
    J Pharm Sci; 1998 Aug; 87(8):931-5. PubMed ID: 9687336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physical state of nafcillin sodium in frozen aqueous solutions and freeze-dried powders.
    Milton N; Nail SL
    Pharm Dev Technol; 1996 Oct; 1(3):269-77. PubMed ID: 9552309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.